Karenitecin: Began Phase I study

BioNumerik Pharmaceuticals Inc., San Antonio, Texas Product: Karenitecin Business: Cancer Therapeutic category: Apoptosis Target: DNA Description: Silicon-containing camptothecin, DNA-binding topois...